Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cloxacillin antibiotic lock solution for prevention of catheter-associated infection in hemodialysis patients
IRCT20120215009014N272Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2019
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in catheter-associated urinary tract infection (CAUTI) comparing Cloxacillin lock solution with Placebo lock solution (2 arms). Primary endpoint: Catheter-associated infection. Started May 2019; status: completed.
02
Drugs
cloxacillin
03
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on IRCT20120215009014N272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N272.